Actively Recruiting
Study on Predicting Intensive Care Outcomes Using Carbohydrate-Deficient Transferrin Levels at Admission
Led by Medical University of Vienna · Updated on 2026-07-06
800
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
This observational study aims to determine whether hazardous alcohol consumption, measured by carbohydrate-deficient transferrin CDT levels at intensive care unit ICU admission, is linked to worse outcomes in critically ill adult patients admitted through the emergency department. The main focus is to see if elevated CDT levels predict higher short-term mortality and other adverse clinical events in non-traumatic ICU patients. Participants will have CDT levels measured from routine blood samples taken at ICU admission. The study involves no changes to standard care and does not administer any treatment. Researchers will observe and analyze clinical outcomes such as 30-day mortality, ICU length of stay, duration of mechanical ventilation, delirium, renal replacement therapy, and ICU readmission rates. During the study, clinical data will be collected throughout hospitalization and follow-up. The primary outcome is all-cause mortality within 30 days of ICU admission. Secondary outcomes include in-hospital mortality, illness severity scores, and duration of ventilation and ICU stay, assessed up to six months after study inclusion. The study is sponsored by the Medical University of Vienna and will follow participants from ICU admission through their hospital course and recovery period.
CONDITIONS
Brief Title
Intensive Care Outcome Prediction Using Admission Carbohydrate-deficient Transferrin
Research Team
J
Juergen Grafeneder, MD, PhD MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here